This Week in Cardiology cover art

This Week in Cardiology

This Week in Cardiology

Written by: Medscape
Listen for free

About this listen

This podcast delivers Dr. John Mandrola's summary and perspective on top news of the week that cardiologists can't miss. This podcast is intended for US health professionals only.Copyright 2019, Medscape Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Apr 17 2026 This Week in Cardiology
    Apr 17 2026

    SPIRIT-HF, another spironolactone trial in HFpEF; the ESSENCE imaging study of the drug olezarsen; the SirPAD trial in peripheral artery disease; and ultrasound-guided femoral venous access are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I ACC: SPIRIT-HF Trial

    • FINEARTS-HF Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2407107
    • TOPCAT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1313731
    • TOPCAT Americas Trial https://www.ahajournals.org/doi/10.1161/circulationaha.114.013255

    II A New Class of Lipid Lowering Drug Has a Dubious Debut At ACC

    • ESSENCE-TIMI 73b Imaging Study https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.080012
    • ESSENCE-TIMI 73b Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2507227
    • IMPROVE IT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1410489

    III Drug-Coated Balloons Looked Quite Good in PAD interventions

    Sirolimus-Coated Balloon Reduces Amputation Risk in Peripheral Artery Disease

    https://www.medscape.com/viewarticle/sirolimus-coated-balloon-reduces-amputation-risk-peripheral-2026a1000a83

    • SirPAD trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600360

    IV Another Vascular Story from the European Heart Rhythm Association

    • ULYSSES Trial https://doi.org/10.1093/eurheartj/ehag291
    • ULTRA-FAST Trial https://doi.org/10.1093/europace/eux175

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    28 mins
  • Apr 10 2026 This Week in Cardiology
    Apr 10 2026

    Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I IVUS-Guided PCI

    • OPTIMAL Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600440
    • IVUS-CHIP Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601521
    • ILUMIEN IV Trial https://www.nejm.org/doi/10.1056/NEJMoa2305861
    • DKCRUSH VIII Trial https://doi.org/10.1016/j.jacc.2026.01.081

    II Ez-PAVE Trial — Low vs Very Low LDL-targets

    Does Ez-PAVE Support 'Lower Is Better' for LDL-C? https://www.medscape.com/viewarticle/does-ez-pave-support-lower-better-ldl-c-2026a1000akx

    • Ez-PAVE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600283
    • 2026 ACC/AHA Lipid Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423

    III CORALreef AddOn

    • CORALreef AddOn Trial https://www.jacc.org/doi/abs/10.1016/j.jacc.2026.03.036
    • This Week in Caardiology 2-6-26 https://www.medscape.com/viewarticle/1003240
    • CORALreef Lipids Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2511002

    IV Another Post-MI Beta-blocker Withdrawal Study: SMART-DECISION

    • SMART-DECISION Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601005
    • ABYSS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    32 mins
  • Apr 03 2026 This Week in Cardiology
    Apr 3 2026

    John Mandrola offers an ACC recap of 5 big trials—Hi-PEITHO, PROTAVI, ORBITA-CTO, CHIPS-BCIS3 and CHAMPION AF

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Catheter Based Fibrinolysis of Pulmonary Embolism –Hi PEITHO

    • Fibrinolysis Treatment Validated in Large Trial for Acute Intermediate-Risk PE https://www.medscape.com/viewarticle/fibrinolysis-treatment-validated-large-trial-acute-2026a10009im
    • Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism (HI PEITHO) https://www.nejm.org/doi/full/10.1056/NEJMoa2516567
    • National Early Warning Score (NEWS) https://www.england.nhs.uk/ourwork/clinical-policy/sepsis/nationalearlywarningscore/

    II PRO-TAVI trial

    • Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI) 10.1016/S0140-6736(26)00308-9 External Link
    • PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation (Notion 3) https://www.nejm.org/doi/full/10.1056/NEJMoa2401513

    III ORBITA CTO Sham vs PCI for Angina Relief

    • Tightly Blinded Trial Confirms PCI Reduces Angina in Obstructive Occlusion https://www.medscape.com/viewarticle/tightly-blinded-trial-confirms-pci-reduces-angina-2026a10009ob
    • A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina - ORBITA-CTO https://www.jacc.org/doi/10.1016/j.jacc.2026.03.027
    • ORBITA 1 10.1016/S0140-6736(17)32714-9 External Link
    • ORBITA 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2310610
    • DECISION CTO https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.031313
    • EuroCTO https://doi.org/10.1093/eurheartj/ehy220

    IV CHIPS BCIS3 Impella Supported High-Risk PCI

    • Adoption Before Evidence: CHIP-BCIS3 Humbles Impella https://www.medscape.com/viewarticle/adoption-before-evidence-chip-bcis3-humbles-impella-2026a10009jh
    • Left Ventricular Unloading in High-Risk PCI (CHIP BCIS3) https://www.nejm.org/doi/full/10.1056/NEJMoa2515704
    • Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock) https://www.nejm.org/doi/full/10.1056/NEJMoa2312572

    V CHAMPION AF – Watchman vs DOAC in Patients With AF

    • CHAMPION-AF Trial Finds LAAC an Alternative for NOAC in Lower-Risk Patients https://www.medscape.com/viewarticle/champion-af-trial-finds-laac-alternative-noac-lower-risk-2026a10009ij
    • Six Reasons Why CHAMPION-AF Should Not Change Practice https://www.medscape.com/viewarticle/six-reasons-why-champion-af-should-not-change-practice-2026a10009i7
    • Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation (CHAMPION AF) https://www.nejm.org/doi/full/10.1056/NEJMoa2517213
    • Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE AF) https://www.nejm.org/doi/full/10.1056/NEJMoa2513310

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    44 mins
No reviews yet